Cargando…
Potential therapeutic role of budesonide to reduce COVID-19 severity
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585565/ https://www.ncbi.nlm.nih.gov/pubmed/34802976 http://dx.doi.org/10.1016/j.jiph.2021.11.003 |
_version_ | 1784597717848162304 |
---|---|
author | Mohiuddin, Md Kasahara, Kazuo |
author_facet | Mohiuddin, Md Kasahara, Kazuo |
author_sort | Mohiuddin, Md |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8585565 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85855652021-11-12 Potential therapeutic role of budesonide to reduce COVID-19 severity Mohiuddin, Md Kasahara, Kazuo J Infect Public Health Editorial The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2022-01 2021-11-12 /pmc/articles/PMC8585565/ /pubmed/34802976 http://dx.doi.org/10.1016/j.jiph.2021.11.003 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Editorial Mohiuddin, Md Kasahara, Kazuo Potential therapeutic role of budesonide to reduce COVID-19 severity |
title | Potential therapeutic role of budesonide to reduce COVID-19 severity |
title_full | Potential therapeutic role of budesonide to reduce COVID-19 severity |
title_fullStr | Potential therapeutic role of budesonide to reduce COVID-19 severity |
title_full_unstemmed | Potential therapeutic role of budesonide to reduce COVID-19 severity |
title_short | Potential therapeutic role of budesonide to reduce COVID-19 severity |
title_sort | potential therapeutic role of budesonide to reduce covid-19 severity |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585565/ https://www.ncbi.nlm.nih.gov/pubmed/34802976 http://dx.doi.org/10.1016/j.jiph.2021.11.003 |
work_keys_str_mv | AT mohiuddinmd potentialtherapeuticroleofbudesonidetoreducecovid19severity AT kasaharakazuo potentialtherapeuticroleofbudesonidetoreducecovid19severity |